Netherlands Alzheimer Foundation Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2000
NCT00432081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now